Jacques Gonella, Director at ANTARES PHARMA, INC. (ATRS), sold 300,000 shares at $2.55 ($762K) on 2018-05-17, disclosed to the SEC on 2018-05-18.
Open-market sale of $762k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.52 | 100,000 | $252K | 33.1% |
| 2 | $2.55 | 100,000 | $255K | 33.5% |
| 3 | $2.55 | 100,000 | $255K | 33.5% |
| Total | $2.54 avg | 300,000 | $762K | 100% |
| Filing → |
| ATRS | SELL | 2018-08-15 | $306K | — | Filing → |
| ATRS | SELL | 2018-08-10 | $1.5M | — | Filing → |
| ATRS | SELL | 2018-06-20 | $2K | — | Filing → |